- Improvement of the cure rates in colon cancer by nationwide trials from 49% to 72 % 5-year-survival rates in lymph node positive tumor stages. Significant improvement of local control in rectal cancer.
- Recognition that surgical results are varying within surgeons and hospitals. Personally and in the nationwide research group standardization of surgical procedures. Personally training nd exchange with the best colon- and rectal surgeons worldwide.
- Fixing the parameters contributing to treatment quality for colon- and rectal cancer surgery (working group KLK, prestigious publications).
- Regular scientific exchange with worldwide top scientists (BIC/ICRCC).
- Excellent results in the surgical-oncological treatment and care of colon- and rectal cancer patients at APK/ATC Wiesbaden.
(click to enlage tables & images)
Slide 1: Improvement of 5-year-survival rates by Professor Link´s team in lymph node positive colon cancer from 49% (surgery only, results of e.g. Universities of Ulm and Erlangen statistics) to 72% (Arm B, FOGT phase III multimodal treatmernt trial). By treatment individualization (see further down „research Professor Link + Team) using molecular biological determinants, survival ma be increased to >85%!
Slide 2: Surgical results are not identical in various hospitals. Interhospital variation of 5-year-survival rates e.g. in lymph node positive colon cancer (stage UICC III) according to Hermanek/Univ.Erlangen ranged from 27% (lowest rate) to 54% (highest rate) at an average of 46.5%.
Slide 3: The survival rates correlate to surgeon´s or hospital´s case load. If the case load is too high, results do not get better, there is even a tendency for reduction of treatment quality (Billingsley, UCLA/CA/USA).
Slide 4: The working group of the KLK, constituted and headed by Professor Link („Konvent Leitender Krankenhauschirurgen“, Association of more than 1000 Dept.Heads in General/Visceral surgical hospital units) defined „parameters of treatment quality“. The fact of interhospital- or surgical quality variation unfortunately is still not known in the public sufficiently.
Slide 5: Due to definition of the treatment procedures and regular study group exchanges, the results of the FOGT-Hospitals did not depend on hospital size (FOGT = Forschungsgruppe Onkologie Gastrointestinale Tumoren (Research Group on Gastrointestinal Tumors), cofounded and headed by Professor Link with 64 participating German hospitals).
Slide 6: FOGT organized regular top scientific meetings and cofounded the International Colon- and Rectal Cancer Club (ICRCC) for interdisciplinar exchange on the topic „Colon- and Rectal Cancer“ (BIC/ICRCC). Main topics of meetings were techniques and quality in surgery, up to date chemotherapy and – radiotherapy for primary tumors (colon- and rectal cancer), liver- and lung metastases, and peritoneal carcinosis.
Slide 7: Benchmarking of surgical quality among 253 German bowel cancer centers (DKG): APK Wiesbaden (FAD-Z102) is rated in the top categories (see red arrow).
Slide 8: surgical oncological longterm results of rectal cancer surgery/multimodal therapy at Bowel Cancer Center APK Wiesbaden: the results may be regarded as outstanding.